1. Home
  2. VCIG vs DCOY Comparison

VCIG vs DCOY Comparison

Compare VCIG & DCOY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VCI Global Limited

VCIG

VCI Global Limited

N/A

Current Price

$5.80

Market Cap

656.7K

ML Signal

N/A

Logo Decoy Therapeutics Inc. Common Stock

DCOY

Decoy Therapeutics Inc. Common Stock

N/A

Current Price

$1.13

Market Cap

674.8K

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VCIG
DCOY
Founded
2013
N/A
Country
Malaysia
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
656.7K
674.8K
IPO Year
2022
2014

Fundamental Metrics

Financial Performance
Metric
VCIG
DCOY
Price
$5.80
$1.13
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 2.5M
55.7K
Earning Date
10-16-2026
11-20-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$20.42
P/E Ratio
$1.81
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.16
$0.53
52 Week High
$23.40
$67.68

Technical Indicators

Market Signals
Indicator
VCIG
DCOY
Relative Strength Index (RSI) 73.47 37.32
Support Level $0.57 $0.90
Resistance Level $11.58 $1.24
Average True Range (ATR) 0.88 0.08
MACD 0.69 0.07
Stochastic Oscillator 63.63 64.71

Price Performance

Historical Comparison
VCIG
DCOY

About VCIG VCI Global Limited

VCI Global Ltd is a holding company. The principal activities of the Company and its subsidiaries are the provision of business Strategy consultancy and technology development. The firm organized its consulting services into three main segments: Business Strategy Consultancy; Technology development, solutions and consultancy; and Others. It derives the majority of its revenue from the Business Strategy Consultancy segment, which focuses on listing solutions, investor relations, and boardroom strategies consultancy.

About DCOY Decoy Therapeutics Inc. Common Stock

Decoy Therapeutics Inc is a pre-clinical stage biotechnology company focused on advancing its pipeline of peptide conjugate therapeutics engineered through its proprietary IMP3ACT platform. The IMP3ACT platform represents a paradigm shift in peptide conjugate drug discovery and manufacturing, leveraging machine learning (ML) and artificial intelligence (AI" tools alongside high-speed synthesis techniques to rapidly engineer, optimize and manufacture peptide conjugates that target serious unmet medical needs. The company manages its business in one operating segment, focused on the discovery and development therapeutics for patients with high, unmet medical needs. Its pipeline programs include: Pan-Coronavirus; and Tripledemic.

Share on Social Networks: